Literature DB >> 35368813

Overview of The Human Heredity and Health in Africa Kidney Disease Research Network (H3A-KDRN).

Dwomoa Adu1, Akinlolu Ojo2.   

Abstract

Entities:  

Keywords:  Africa; apolipoprotein L1; chronic kidney disease; clinical nephrology; genetics

Mesh：

Year:  2020        PMID： 35368813      PMCID： PMC8785727          DOI： 10.34067/KID.0002592020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  10 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa.

Authors:  Charlotte Osafo; Yemi Raheem Raji; David Burke; Bamidele O Tayo; Nicki Tiffin; Marva M Moxey-Mims; Rebekah S Rasooly; Paul L Kimmel; Akinlolu Ojo; Dwomoa Adu; Rulan S Parekh
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 8.237

Review 3.  Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review.

Authors:  Gloria Ashuntantang; Charlotte Osafo; Wasiu A Olowu; Fatiu Arogundade; Abdou Niang; John Porter; Saraladevi Naicker; Valerie A Luyckx
Journal:  Lancet Glob Health       Date:  2017-02-20       Impact factor: 26.763

4.  High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.

Authors:  Ifeoma I Ulasi; Shay Tzur; Walter G Wasser; Revital Shemer; Etty Kruzel; Elena Feigin; Chinwuba K Ijoma; Obinna D Onodugo; Julius U Okoye; Ejikeme B Arodiwe; Ngozi A Ifebunandu; Chinwe J Chukwuka; Cajetan C Onyedum; Uchenna N Ijoma; Emmanuel Nna; Macaulay Onuigbo; Saharon Rosset; Karl Skorecki
Journal:  Nephron Clin Pract       Date:  2013-07-13

Review 5.  The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  John W Stanifer; Bocheng Jing; Scott Tolan; Nicole Helmke; Romita Mukerjee; Saraladevi Naicker; Uptal Patel
Journal:  Lancet Glob Health       Date:  2014-02-10       Impact factor: 26.763

Review 6.  APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.

Authors:  Barry I Freedman; Sophie Limou; Lijun Ma; Jeffrey B Kopp
Journal:  Am J Kidney Dis       Date:  2018-11       Impact factor: 8.860

7.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Authors:  Shay Tzur; Saharon Rosset; Revital Shemer; Guennady Yudkovsky; Sara Selig; Ayele Tarekegn; Endashaw Bekele; Neil Bradman; Walter G Wasser; Doron M Behar; Karl Skorecki
Journal:  Hum Genet       Date:  2010-07-16       Impact factor: 4.132

8.  The gap between estimated incidence of end-stage renal disease and use of therapy.

Authors:  Shuchi Anand; Asaf Bitton; Thomas Gaziano
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

9.  Developing the science and methods of community engagement for genomic research and biobanking in Africa.

Authors:  P Tindana; M Campbell; P Marshall; K Littler; R Vincent; J Seeley; J de Vries; D Kamuya
Journal:  Glob Health Epidemiol Genom       Date:  2017-09-04

10.  H3Africa partnerships to empower clinical research sites to generate high-quality biological samples.

Authors:  Talishiea Croxton; Ndidi Agala; Emmanuel Jonathan; Olasinbo Balogun; Petronilla J Ozumba; Enzenwa Onyemata; Shefiya Lawal; Manmak Mamven; Samuel Ajayi; Sylvia E Melikam; Mayowa Owolabi; Bruce Ovbiagele; Dwomoa Adu; Akinlolu Ojo; Christine M Beiswanger; Alash'le Abimiku
Journal:  Afr J Lab Med       Date:  2020-03-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.